There is evidence indicating that different tumor types and subtypes lead to various degrees of disruption of the BBB; for example, studies suggest that triple negative breast cancer patients have more disruption in the BBB with brain metastases then HER2 positive patients [15]. The gene discussed is ERBB2; the disease is neoplasm.